New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Willow Biosciences Inc.
CANSF
Shape
US Flag

PNK

Unprofitable

EPS improving

Unprofitable

EPS improving

9M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

9M

Drug Manufacturers - Specialty & Generic

Next Earning date - 12 Nov 2024

0.07USD
0.00 ( 0.00%)
Market Open
favorite-chart

Relative Strenght

favorite-chart

Volume Buzz

-39%
favorite-chart

Earning Acce

Yes
favorite-chart

Dist 52w H.

38%

Quote Panel

Shape
Updated October 22, 2024
1W -7.14 % 1M -17.20 % 3M -2.55 % 1Y -1.52 %

Key Metrics

Shape
  • Market Cap

    9.37M


  • Shares Outstanding

    144.20M


  • Share in Float

    106.09M


  • Dividende

    0


  • Earning Date

    12 Nov 2024


  • Price Target

    0.065


  • Average Volume

    33553


  • Beta

    1.127


  • Range

    0.05-0.105


  • Industry

    Drug Manufacturers - Specialty & Generic


  • Website

    https://www.willowbio.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

7.04x

P/S Ratio

-207.83x

P/B Ratio

-25.1

Debt/Equity

-472.8%

Net Margin

$-0.0

EPS

How CANSF compares to sector?

P/E Ratio

Relative Strength

Shape

CANSF

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape

$259M

Shape25134%

2025-Revenue

0

$259M

Shape-23588%

2025-EBITDA

Analyst rating

No Data Available

Last analyst upgrade/downgrade

No Data Available

Earnings GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

N/A

-0.02
vs -0.10

Q2.22

arrow
arrow

N/A

-0.03
vs 0.05

Q3.22

arrow
arrow

N/A

-0.03
vs 0.03

Q4.22

arrow
arrow

N/A

-0.04
vs -0.04

Q1.23

arrow
arrow

N/A

-0.04
vs -0.02

Q2.23

arrow
arrow

N/A

-0.03
vs -0.03

Q3.23

arrow
arrow

N/A

-0.02
vs -0.03

Q4.23

arrow
arrow

N/A

-0.02
vs -0.04

Q1.24

arrow
arrow

N/A

-0.02
vs -0.04

Q2.24

arrow
arrow

N/A

-0.01
vs -0.03

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

-100%

NA  vs 6K

Q2.22

arrow
arrow

+126%

262K  vs 116K

Q3.22

arrow
arrow

+2350%

49K  vs 2K

Q4.22

arrow
arrow

+5567%

510K  vs 9K

Q1.23

arrow
arrow

NA

274K  vs NA

Q2.23

arrow
arrow

-48%

135K  vs 262K

Q3.23

arrow
arrow

+1276%

674K  vs 49K

Q4.23

arrow
arrow

-83%

89K  vs 510K

Q1.24

arrow
arrow

-81%

51K  vs 274K

Q2.24

arrow
arrow

+660%

1M  vs 135K

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-19%

-0.19
vs -0.13

Q4.22

arrow
arrow

-29%

-0.29
vs -0.19

Q1.23

arrow
arrow

-41%

-0.41
vs -0.29

Q2.23

arrow
arrow

-44%

-0.44
vs -0.41

Q3.23

arrow
arrow

-39%

-0.39
vs -0.44

Q4.23

arrow
arrow

-71%

-0.71
vs -0.39

Q1.24

arrow
arrow

-153%

-1.53
vs -0.71

Q2.24

arrow
arrow

+3067%

30.67
vs -1.53

Institutionnal OwnershipShape

status-up

Earnings Growth

Latest News